Public Citizen Seeks Action On Ads To US Doctors

15 September 1996

In a letter to US Food and Drug Administration Commissioner David Kessler, Public Citizen's Health Research Group director Sidney Wolfe has asked the agency to step up enforcement of FDA laws covering drug advertising aimed at physicians. Dr Wolfe cites widespread violations of these laws, and urges the FDA to issue more official warning letters and recruit a larger staff to work on these problems.

Enclosed with the letter is a copy of an article written by Dr Wolfe for The Lancet (September 5) which discusses what he calls "the demeaning way, inside the drug industry, that physicians are viewed, brainwashed and conquered." He points out that there are two main remedies to counter such campaigns - either to try to immunize doctors against "these often false and misleading advertising campaigns by much more education" during their training so that they have needed scientifically-based knowledge for prescribing decisions, or use FDA enforcement to stop false and misleading advertising campaigns which Dr Kessler himself has "stated can result in 'needless injury or even death'."

Dr Wolfe points out that widespread violations of advertising regulations are not only documented by outside reviewers, who have found potential violations in 92% of ads, but also in current information from the FDA.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight